Marie-Ange Noue is a PhD chemist trained at Curie University in Paris and at the University of Houston. She started her career working as a research scientist in petrochemicals. She later found her niche upon joining EMD Serono in 2008, where she’s held a number of positions of increasing responsibility. In her current role as Senior Director, Head of US Scientific Communications, she provides strategic leadership and oversight for activities related to Medical Information, Medical Communication, Medical Training, and Medical Education for the US. Marie-Ange chairs the Board of Directors of the Canadian Medical information network, and serves as Vice President on the Executive Board of PhactMI.

Elizabeth Brown is a Senior Director and TA Lead of Oncology Medical Writing at Merck & Co, Inc. near Philadelphia, PA. She has led regulatory projects and initiatives in the pharmaceutical industry for 20+ years. First as a laboratory scientist, then as a clinical researcher, and currently as a medical writer. Elizabeth brings a project and people management focus to her role as a regulatory medical writer and department leader. With this focus, she has developed a passion for developing people, advising teams and providing strategic guidance how to deliver efficient, effective, and high-quality documents.

Elizabeth C. Froom, PharmD, is a Senior Director in the Medical Writing and Healthcare Communications team at Evidera. She has over 20 years of medical information and writing experience. In her role she provides strategic direction and oversight to a global team of medical writers who deliver medical information services including standard response documents, custom responses, Academy of Managed Care Pharmacy (AMCP) dossiers, infographics, and promotional review. Her educational background includes a BS in pharmacy and a PharmD from the University of South Carolina College of Pharmacy.

Dr. Kulkarni is Principal Attorney for the Kulkarni Law Firm which focuses on providing legal and regulatory solutions to pharmaceutical companies and their providers. He is a pharmacist & lawyer and advises clients on bringing their product to market, focusing on post IND thru commercialization and genericization.

As ever-questioning medical communication professional with an international reputation, I have been communicating science to children, grandmothers, business professionals, government agencies, and scientific experts for more than 15 years. My technical areas of expertise span across infectious disease, immunology, oncology, and vaccines and include content deliverables at all stages within a product's lifecycle.

Brooke has worked within the pharmaceutical industry for the past 9 years starting as an MSL and progressing through escalating field and home office leadership roles. Brooke has led Medical engagement strategies across 15 launches for both small and large molecules and across multiple therapeutic areas. Brooke is currently the Head of Medical Affairs Strategy and Operations for GSK

Dr. Nimita Limaye leads R&D Strategy and Technology at IDC Health Insights, providing research-based advisory and consulting services on the Life Sciences industry. She represents Healthcare and life science on IDC's AI Council. She is an executive business leader with more than two decades of life sciences leadership experience in the pharma/CRO/tech consulting industry. She focuses on the role of data and technology in transforming drug development, RWD, synthetic data and analyzing and predicting evolving trends in the life sciences industry. Nimita was the chair of the SCDM board, chaired several conferences roundtables, given keynote talks, participated in fireside chats, and authored close to a 100 thought leadership papers.

Fabiana Ebihara has over 18 years of extensive experience in the field of medical writing, with a particular focus on leadership and regulatory affairs. Throughout her career, Fabiana has held several key leadership positions at Parexel International, where she has played a pivotal role in managing partnerships with large pharmaceutical companies. She provided financial and operational oversight and led projects covering a range of therapeutic areas. Fabiana has successfully implemented process improvements, mentored teams, and contributed to business development efforts.

Richard Swank is the former head of US Field Medical and Global Field Medical Excellence at Amgen and Founder of Scientific Engagement LLC. He has spent most of his career building medical capabilities in Medical Affairs, including building and managing MSL teams, managing medical information call centers, and improving how medical teams execute and measure field medical performance. He has a PhD in Biochemistry and Molecular Biology and prior to joining industry completed an NIH Postdoctoral Fellowship and was a senior fellow in Medical Genetics at the University of Washington.

Iris Tam, PharmD, FAMCP, is Senior Vice President & Head of Medical Affairs and HEOR at COEUS Consulting with over 30 years of experience in health care, including hospital pharmacy, managed care pharmacy, and the biopharmaceutical industry. In previous industry roles, she led Medical Affairs strategies and tactics that support market access, product value, and patient access, including accountabilities for medical communications, HEOR, AMCP dossiers, compendia submissions, guideline bodies engagement, and payer communications. From 2008 to 2021, Iris served on the AMCP Format Executive Committee which oversees the AMCP Format for Formulary Submissions for dossier development, including serving as the Chair for the last 3 years.

Sarah Jarvis leads our Global Medical Affairs consulting space at ZS. Based now in San Francisco, California, Sarah has worked in the lifesciences industry for over 25 years and has focused exclusively on working with medical affairs clients for the past 15 years at ZS. ZS has worked with more than 100 companies' Medical Affairs organizations. Sarah also previously worked at Genentech in a variety of different roles on products that spanned therapy areas and phases of the lifecycle. With COVID acting as an accelerator on the medical function, ZS is partnering with clients to support the growth and change needed to meet global demands - in the field and in headquarters - through strategy, advanced analytics, and operations projects.

In her 25+ years of industry experience, Lynn has served in both individual and leadership positions within Medical Affairs at both large and start-up companies. She is currently Sr. Director, Medical Science Liaisons at BridgeBio, where she is building and leading a field medical team in the rare cardiovascular therapeutic area. Lynn is a transformative leader with proven excellence in building & developing high performing teams. Along with her leadership positions, Lynn is very active in growing/expanding the MSL profession across the industry and is a frequent invited speaker. She has also authored/ co-authored several MSL surveys highlighting and assessing the MSL role.

In Craig’s more than 30 years working at Lilly, he has successfully worked in various positions in multiple therapeutic areas including neuroscience, diabetes and osteoporosis. Craig is a founding member of the Medical Science Liaison (MSL) program at Lilly where he worked in the New York City Metropolitan area for over 13 years in this field role. Craig spent 6 years as the MSL Trainer for Lilly USA and in 2017 became part of the Office of Medical Professional Development where is he assumed the role of the Global MSL trainer. Craig has been very active in developing benchmarking survey data on MSL standards across the pharmaceutical industry. Craig received the DIA Excellence in Service award in 2021.

Jim Wilkinson, PhD is an executive leader in global and US Medical Affairs, with over 22 years in the biopharma industry. His experience includes leading Global/US Medical Information, Global Publications, Global/US Medical Communications, Global Field-Based Medical, and US Medical Science Liaison (MSL) teams. Jim has worked in multiple therapeutic areas while also launching multiple products throughout the course of his career. He has extensive working knowledge of the commercialization process, compliance, product launches, company/product acquisition and integration, legal and regulatory guidelines, operations, omnichannel communications, and promotional review. Jim received his B.S. from UW-Madison and his Ph.D. from UM-Minneapolis.

John Jones is an experienced IT Strategist focused on developing innovative technology solutions for unmet business needs in Life Sciences. John is currently the Founder and CEO of Entitech Solutions, a Life Sciences focused IT Software and Consulting firm. Prior to starting his company, John led Quintiles’ IT Consulting Division from 2010 – 2015 focusing on IT Advisory and Implementation services in Life Sciences. John has more than 20 years experience in developing and delivering IT Solutions for various companies, and has extensive experience in the clinical, regulatory, and commercial areas.

Lisa Chamberlain James is a Senior Partner and Chief Executive Officer of Trilogy Writing & Consulting. Aside from management activities, she also leads client projects, with extensive experience in a variety of documents and a special interest in drug safety and patient information. After receiving her Ph.D. in Pathology, Lisa began her medical writing career in Cambridge in 2000. Since then, she has been heavily involved in the EMWA on the Education Committee and as a workshop leader, is a visiting lecturer for King’s College London, initiated and chaired the EMWA PV and Communicating with the Public SIGs, is chair of the Geoff Hall Scholarship Committee, section editor for Medical Writing, and a Fellow of the Royal Society of Medicine.

After receiving her PhD in Developmental Neurobiology, Julia became a medical writer in 1997. In 2002, she co-founded Trilogy Writing & Consulting, a company specialized in medical writing of regulatory documentation. As a Senior Partner she continues to bring her enthusiasm and experience to client projects. She has twice been President of the European Medical Writers Association (EMWA), is an experienced trainer of medical writers, and runs workshops for EMWA, AMWA, DIA, and pharma companies around the world.

Evelyn R. Hermes-DeSantis, PharmD, BCPS, is the Director for Research and Publications for phactMI and Professor Emerita at the Ernest Mario School of Pharmacy at Rutgers, the State University of New Jersey. She is dedicated to advancing and elevating the practice of medical information. She received both a BS in Pharmacy and a PharmD from Rutgers and completed a Drug Information specialty residency at the Medical College of Virginia Hospital in Richmond, Virginia prior to working at the University of Utah Hospital Drug Information Service. For 25 years she was the Director of Drug Information Services at Robert Wood Johnson University Hospital and a Clinical Professor at the Ernest Mario School of Pharmacy at Rutgers.

Valerie Huh brings over 20 years of expertise in the pharmaceutical, healthcare, and education sectors. She holds a Pharm.D and an MBA, and she is passionate about leveraging advanced technology and new ways of working to improve operational efficiency. In her current role, she is dedicated to enhancing customer journeys by innovating processes within medical information contact centers.

Jones is an Associate Partner at ZS Associates, a Global Healthcare Management Consulting Firm and leads the Medical Omnichannel / Digital Transformation Domain. He has over a decade of experience and worked with 20+ pharma organizations across omnichannel / digital domains spanning strategy, technology and analytics. He has supported organizations in areas like digital and omnichannel strategy & roadmapping, technology ecosystems, digital blueprint and activation, engagement process redesign, omnichannel orchestration, digital analytics and reporting Jones holds an MBA from Washington University in St. Louis and a Bachelors Degree in Electronics and Communication Engineering from Cochin University, India

Jeff is a senior HEOR leader, with a focus on generating and communicating value evidence for payor audiences. Jeff led the Global Health Outcomes and Payer MSL teams at Allergan after several years as International Director of Pharmacoeconomics at Glaxo. Jeff is an ACCP Fellow, led development of ACCP's pharmacoeconomics fellowship training programs, and was Chair of the AMCP Format Executive Committee, where he led development of the AMCP Format 4.0. He also actively supported AMCP's advocacy efforts around preapproval information exchange in Congress. At Lumanity, Jeff is the US Region Lead within the Value Demonstration Practice, advising clients across the spectrum of value evidence generation and communication activities.

Dr. Oladayo Oyelola is Senior Director and Head, Clinical Trial Information Disclosure at Daiichi Sankyo. He oversees corporate clinical trial transparency/data sharing strategies and compliance activities; coordinates internal disclosure operations’ training, process improvements and trial transparency policy intelligence. He holds a PhD in Clinical Chemistry from Obafemi Awolowo Univ. Ile-Ife, Nigeria, 1990 and received The Rockefeller Foundation Postdoctoral Fellowship, 1991 and National Mentor Role Model Award of Minority Access Inc/Office of Minority Health, NIH, 2001. Dr. Oyelola has over 35 years’ experience in biomedical R&D, and certifications by National Registry of Certified Chemists and American Society for Clinical Pathologist

Vladimir Penkrat is AVP of Regulatory Affairs at Indegene. With an MBA in International Business, Vladimir has provided strategic leadership throughout his career across R&D functional areas including clinical development, biometrics, biostatistics, medical writing, pharmacovigilance, and regulatory affairs. Over the past three decades Vladimir has experience in top pharmaceutical, biotech startups, CROs, and consulting firms. Vladimir's leadership has enabled clients’ businesses to prepared and adapt to the evolving digital landscape and prepare for changes. As a business leader he has scaled business operations greater than 500 FTE in size globally to deliver services across the R&D landscape.

> 10 years experience of writing in the pharmaceutical industry. Before joining PAREXEL Medical Writing Services in Jan 2003 he was the Deputy Executive Editor for IMS Health’s R&D Focus. James completed a PhD in apoptosis, and then did a Post-Doc in the role of apoptosis in endometriosis.

Jeanette Towles, MA, RAC, is the CEO of Synterex, Inc., a woman-owned, disability-owned clinical and regulatory consulting firm specializing in agile-based project management methodology, automation, and AI-driven technologies. Prior to that, she held in-house consulting and FTE medical writing and clinical science positions at both small- and large-size companies, including managing a group of programmers and vendors working on automated documents, with cumulative industry experience of nearly 20 years. She lives in the Boston area with her husband, 2 children, and dog.

Lauren Tulloch is Vice President & Managing Director at CCC. In that role, she is responsible for the Corporate Business Unit which includes copyright licenses, the RightFind product suite, and managed knowledge services. Prior, Tulloch held several product management leadership roles in the organization. Before joining CCC, she served as a group publisher at a healthcare education & training company. Tulloch began her career as a newspaper reporter and editor. She holds a Bachelor’s degree in journalism and political science from Boston University.